Summary
- Current Price
- As of today, MGX price is $1.20, down -3.23% on
- Current Price All-Time High
- MGX price is currently -90.58% below its historical high of $12.74 set on
- Market Cap
- MGX current market cap is $45M, down -34.71% year-over-year
- Revenue
- MGX current annual revenue is $25.21M, down -51.79% year-over-year
- Next Earnings
- As of today, the next earnings release for MGX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Metagenomi Therapeutics, Inc. |
| Ticker | NASDAQ: MGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | metagenomi.co |
| Employees | 119 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.20 | ||
| Price, 1D Change | -3.23% | |
| $45M | ||
| - | ||
| - | ||
| 1.56 | ||
| $25.21M | ||
| Revenue, 1Y Change | -51.79% | |
| -$2.36 | ||
| EPS, 1Y Change | -13.07% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.36 | ||
| EPS Estimate | -$2.50 | N/A |
| EPS Est. Change | -5.99% | N/A |
| $25.21M | ||
| Revenue Estimate | $7.71M | N/A |
| Revenue Est. Change | -69.42% | N/A |
| $1.20 | ||
| Price Target | $7.00 | - |
| Price Tgt. Change | +483.33% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.48 | -$2.09 | +15.97% | |
| -$2.34 | -$2.36 | -0.91% | |
| -$2.50 | N/A | -5.99% | |
| -$1.91 | N/A | +18.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $51.70M | $52.30M | +1.15% | |
| $28.63M | $25.21M | -11.94% | |
| $7.71M | N/A | -69.42% | |
| $8.47M | N/A | -66.39% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -35.14% | ||
| - | ||
| -34.71% | ||
| - | ||
| -51.79% | ||
| +46.57% | ||
| -13.07% | ||
| -102.77% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.20 | ||
| $1.48 | ||
| $1.23 | ||
| $1.53 | ||
| $1.25 | ||
| -$0.01 | ||
| 1.56 | ||
| $0.04 | ||
| 43.45 | ||
| 25.93% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $25.21M | ||
| -$2.36 | ||
| $19.89M | ||
| 78.91% | ||
| -$96.01M | ||
| -380.85% | ||
| -$87.87M | ||
| -348.54% | ||
| -$90.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.26 | ||
| 7.22 | ||
| 7.22 | ||
| - | ||
| 3 | ||
| -2.02 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 3.34 | ||
| 0.40 | ||
| 0.39 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $158.60M | ||
| $160.80M | ||
| $233.28M | ||
| $165.54M | ||
| $74.68M | ||
| $22.93M | ||
| $40.66M | ||
| $6.03M | ||
| $1.49M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $113.08M | ||
| $115.91M | ||
| $5.32M | ||
| $0.00 | ||
| $5.32M | ||
| $0.00 | ||
| -$58.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$88.89M | ||
| $103.53M | ||
| -$356.00K | ||
| $574.00K | ||
| -$89.47M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with MGX
FAQ
- What is the ticker symbol for Metagenomi Therapeutics, Inc.?
- The ticker symbol for Metagenomi Therapeutics, Inc. is NASDAQ:MGX
- Does Metagenomi Therapeutics, Inc. pay dividends?
- No, Metagenomi Therapeutics, Inc. does not pay dividends
- What sector is Metagenomi Therapeutics, Inc. in?
- Metagenomi Therapeutics, Inc. is in the Healthcare sector
- What industry is Metagenomi Therapeutics, Inc. in?
- Metagenomi Therapeutics, Inc. is in the Biotechnology industry
- What country is Metagenomi Therapeutics, Inc. based in?
- Metagenomi Therapeutics, Inc. is headquartered in United States
- When did Metagenomi Therapeutics, Inc. go public?
- Metagenomi Therapeutics, Inc. initial public offering (IPO) was on February 9, 2024
- Is Metagenomi Therapeutics, Inc. in the S&P 500?
- No, Metagenomi Therapeutics, Inc. is not included in the S&P 500 index
- Is Metagenomi Therapeutics, Inc. in the NASDAQ 100?
- No, Metagenomi Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Metagenomi Therapeutics, Inc. in the Dow Jones?
- No, Metagenomi Therapeutics, Inc. is not included in the Dow Jones index
- When was Metagenomi Therapeutics, Inc. last earnings report?
- Metagenomi Therapeutics, Inc.'s most recent earnings report was on August 13, 2025
- When does Metagenomi Therapeutics, Inc. report earnings?
- The date for Metagenomi Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MGX Official Website metagenomi.co
- MGX Profile on Yahoo Finance finance.yahoo.com/quote/MGX
- MGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mgx